In This Section

All Advocacy

Keep up with breaking news on policy decisions and legislation affecting biomedical research, research funding opportunities, regulations, and other important matters impacting pharmacology and pharmacologists.

Refine Results
  • icon-advocacy-news November 9, 2015 NSF Revises Grant Application Policies
      The National Science Foundation (NSF) announced revisions to its Proposal & Award Policies & Procedures Guide (PAPPG) on October 16. The new PAPPG will be effective for proposals submitted or due on or after January 25, 2016. The revisions include:  Enforcement of 5 pm deadline in submitter’s local time across all NSF funding opportunities  Implementation of NSF’s Public Access Policy  …
  • icon-advocacy-statement October 19, 2015 ASPET Responds to FDA Request for Comments on Ketamine Rescheduling
      On October 5th, the U.S. Food and Drug Administration (FDA) issued a request for comments regarding the abuse potential, actual abuse, medical usefulness, trafficking and impact of scheduling changes on the availability for medical use of 10 drug substances, including ketamine. ASPET has submitted comments articulating the Society’s objection to object to any adoption of an international regul…
  • icon-advocacy-statement October 19, 2015 ASPET Joins FASEB’s 125,000 Researchers in Letter Calling on Congress to Raise Spending Caps, Increase Science Funding
      ASPET President Dr. Kenneth Thummel joined over 20 FASEB Society Presidents in signing a letter urging Congress to raise the spending caps and pass a bipartisan budget that includes increased funding for scientific research. Earlier this year, the importance of federal investment in biological and biomedical science and research was recognized by the House and Senate Appropriations Committees…
  • icon-advocacy-news October 19, 2015 Senate Appropriations Hearing on NIH
      The Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies met in an open session at 10:00AM on Wednesday, Oct 7th, 2015 in Room SD-124 of the Dirksen Senate Office Building. The hearing was entitled NIH: Investing in a Healthier Future. During the subcommittee hearing, Senator Patty Murray (D-WA) asked Collins about the effect Congress's failure to come to t…
  • icon-advocacy-news October 19, 2015 No Mandatory Money in Senate Innovations
    CQ HealthBeat reports that it is unlikely mandatory funding for research will be included in the Senate's version of the House's 21st Century Cures Act. According to reports, there are similar increases in the underlying agency authorizations in both bills, but due to a lack of viable offsets, the Senate will not include a mandatory fund in its "Innovations" legislation. This does not mean that m…
  • icon-advocacy-news October 19, 2015 Legislative Update: October 19, 2015
      More on the CR; Budget Negotiations Expected to Begin Soon; Senate Committee Holds Hearing on NIH Funding; Speaker Shakeup Continues; No Mandatory Spending in Senate Innovations   As previously reported, the House and Senate passed a continuing resolution (CR) that will fund federal government agencies through December 11th and the President signed the bill into law before midnight, averting a …
  • icon-advocacy-news October 2, 2015 Congress Passes CR to Fund Government through December 11th
      This week the House and Senate passed a continuing resolution (CR) that will fund federal government agencies through December 11th and the President signed the bill into law before midnight, averting a government shutdown. The CR allows agencies to fund FY2016 programs at the FY2015 level ($1.017 trillion for the total government). From a political standpoint, however, nothing was resolved; …
  • icon-advocacy-news September 29, 2015 National Academies Releases Recommendations for a New Regulatory Framework
        This week the National Academies released a report titled, “Optimizing the Nation's Investment in Academic Research: A New Regulatory Framework for the 21st Century, Part 1.” The report details the expansion of the federal regulatory system and asserts that the current regulatory framework is negatively impacting the effectiveness of the US research investment by allowing administrat…
  • icon-advocacy-news September 29, 2015 New FASEB Factsheet calls on Congress to Restore NIH Funding
      FASEB kicked off an autumn advocacy campaign this month to encourage lawmakers to increase funding for research in the United States. In preparation for upcoming congressional budget negotiations, FASEB released a new research funding factsheet urging members of Congress to pass a fiscal year 2016 budget bill that includes a 5.8 percent increase for the National Institutes of Health (NIH). The …
  • icon-advocacy-news September 29, 2015 ASPET Coalition Partner Praises New FDA Science Board Report
      The Alliance for a Stronger FDA has issued a statement praising the newly released FDA Science Board Report titled, “Mission Possible: How FDA Can Move at the Speed of Science”, asserting that the report reinforces the need for additional resources. This report follows up on the 2007 report, “FDA Science and Mission at Risk,” which brought attention to several deficiencies within the agency. The…

Job Postings